Online citations, reference lists, and bibliographies.
← Back to Search

Value Of Podoplanin As An Immunohistochemical Marker In Tumor Diagnosis: A Review And Update

N. Ordóñez
Published 2014 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Podoplanin is a type I integral membrane glycoprotein that, because it is expressed in lymphatic endothelium, but not in vascular blood vessel endothelial cells, is commonly used in the identification of lymphatic endothelial differentiation in vascular endothelial neoplasms and lymphatic invasion by tumor. Because podoplanin is also expressed in mesothelial cells and fetal gonocytes, it has proved to be a useful marker for assisting in the differential diagnosis of mesotheliomas and germ cell tumors, particularly seminomas/dysgerminomas. Podoplanin expression has also been reported in a wide variety of other neoplasms, including hemangioblastomas, meningiomas, cartilaginous tumors, and follicular dendritic cell neoplasms. This article reviews the information that is currently available on the application of podoplanin immunostaining in diagnostic pathology.
This paper references
10.1016/S0002-9440(10)63851-5
Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells.
S. Hirakawa (2003)
Comparison of Ulex europaeus I lectin and factor VIII-related antigen in vascular lesions.
N. Ordóñez (1984)
10.1111/j.1365-2559.2009.03322.x
Caveolin‐1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma
V. Amatya (2009)
10.1016/J.HUMPATH.2005.01.019
D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.
N. Ordóñez (2005)
10.14670/HH-17.863
Lymphangiogenesis and breast cancer metastasis.
G. Cunnick (2002)
10.1074/JBC.270.30.17815
Identification of a 40-kDa Cell Surface Sialoglycoprotein with the Characteristics of a Major Influenza C Virus Receptor in a Madin-Darby Canine Kidney Cell Line (*)
G. Zimmer (1995)
10.1002/cncr.22477
Novel marker D2‐40, combined with calretinin, CEA, and TTF‐1
T. Mimura (2007)
10.1097/PAS.0b013e31806841f6
Improved Methods of Detection of Lymphovascular Invasion Demonstrate That It is the Predominant Method of Vascular Invasion in Breast Cancer and has Important Clinical Consequences
R. Mohammed (2007)
10.1159/000093091
D2-40: A Reliable Marker in the Diagnosis of Pleural Mesothelioma
A. Müller (2006)
10.1007/s00401-005-0999-3
D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish hemangioblastomas from renal cell carcinomas
S. Roy (2005)
10.1007/s00428-008-0720-8
VEGF-C and VEGFR-3 in a series of lymphangiomas: Is superficial lymphangioma a true lymphangioma?
E. Itakura (2008)
10.1111/j.1600-0463.2009.02461.x
Markers aiding the diagnosis of chondroid tumors: an immunohistochemical study including osteonectin, bcl-2, cox-2, actin, calponin, D2-40 (podoplanin), mdm-2, CD117 (c-kit), and YKL-40
S. Daugaard (2009)
10.1038/modpathol.3880178
Splenic Angiosarcoma: A Clinicopathologic and Immunophenotypic Study of 28 Cases
T. Neuhauser (2000)
10.1038/modpathol.2010.46
The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin
M. Mahalingam (2010)
10.1097/00000478-199304000-00001
Kaposiform Hemangioendothelioma of Infancy and Childhood: An Aggressive Neoplasm Associated with Kasabach-Merritt Syndrome and Lymphangiomatosis
L. Zukerberg (1993)
10.1001/ARCHDERM.1997.03890480093014
Kaposiform hemangioendothelioma. An aggressive, locally invasive vascular tumor that can mimic hemangioma of infancy.
K. Vin-Christian (1997)
10.1309/4GMREAULY257R3AY
Diffuse membranous immunoreactivity for podoplanin (D2-40) distinguishes primary and metastatic seminomas from other germ cell tumors and metastatic neoplasms.
H. Yu (2007)
10.1038/modpathol.3800259
Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma
Albert Y Chu (2005)
Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells.
N. Jørgensen (1995)
10.1038/modpathol.3800153
Infantile hemangiomas are arrested in an early developmental vascular differentiation state
Soheil S. Dadras (2004)
10.1136/jcp.48.11.1011
Immunostaining for CD31 and CD34 in Kaposi sarcoma.
R. Russell Jones (1995)
10.1002/(SICI)1097-0142(19991201)86:11<2406::AID-CNCR31>3.0.CO;2-E
Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors
T. Partanen (1999)
10.1111/j.1600-0560.2010.01517.x
Value of p63 and podoplanin (D2‐40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases
J. Plaza (2010)
10.1007/s00428-007-0376-9
D2-40 labeling in lymphangiomyoma/lymphangiomyomatosis of the soft tissue: further evidence of lymphangiogenic tumor histogenesis
T. Hansen (2007)
10.1016/j.humpath.2012.05.014
Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update.
N. Ordóñez (2013)
10.1038/modpathol.2011.202
Mesotheliomas with small cell features: report of eight cases
N. Ordóñez (2012)
10.1007/s00428-010-0915-7
Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations
M. Kreppel (2010)
10.3892/mmr.2012.911
Expression of podoplanin in salivary gland adenoid cystic carcinoma and its association with distant metastasis and clinical outcomes
He-ming Wu (2012)
10.1111/j.0303-6987.2004.00192.x
Hobnail hemangiomas (targetoid hemosiderotic hemangiomas) are true lymphangiomas
F. E. Franke (2004)
Epitope-specific antibodies to the 43-kD glomerular membrane protein podoplanin cause proteinuria and rapid flattening of podocytes.
Keiji Matsui (1998)
10.1136/jcp.2007.049544
D2-40 is a sensitive and specific marker in differentiating primary adrenal cortical tumours from both metastatic clear cell renal cell carcinoma and phaeochromocytoma
L. Browning (2007)
10.1006/DBIO.1995.1024
Cloning, characterization, and development expression of a rat lung alveolar type I cell gene in embryonic endodermal and neural derivatives.
A. Rishi (1995)
10.1111/j.1440-1789.2010.01109.x
Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma
A. Rivera (2010)
10.1038/modpathol.3800269
Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix
Kimberly L. Dumoff (2005)
SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis.Mod Pathol. 2008;21:1461–1469
GJ Oakley (2014)
Isolation of a gene sequence induced later by tumor-promoting 12-O-tetradecanoylphorbol-13-acetate in mouse osteoblastic cells (MC3T3-E1) and expressed constitutively in ras-transformed cells.
K. Nose (1990)
10.1097/01.dad.0000249885.11195.15
Cutaneous Immunoreactivity of D2-40 Antibody Beyond the Lymphatics
Amal H A Gomaa (2007)
10.1007/s00795-007-0393-4
Significance of D2-40 expression in the diagnosis of gastrointestinal stromal tumor
N. Kuroda (2007)
M2A antigen (podoplanin) distribution in prepubertal and adult testes and testicular tumors [abstract
IA Sesterhenn (2006)
10.1038/modpathol.3800351
Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinoma
S. Jung (2005)
10.1038/modpathol.2009.176
D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans
B. Bandarchi (2010)
Intrapericardial lymphangioma with podoplanin immunohistochemical characterization of lymphatic endothelial cells.
E. Sinzelle (2000)
Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis.
S. Breiteneder-Geleff (1997)
10.1016/j.humpath.2009.08.021
Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face.
W. Tokuyama (2010)
10.1186/1476-4598-9-48
Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas
J. Rodrigo (2009)
Kasabach-Merritt syndromeassociated kaposiform hemangioendothelioma successfully treated with cyclophosphamide, vincristine, and actinomycin D
B Hu (1998)
10.1097/00000478-200308000-00001
The Immunohistochemical Diagnosis of Mesothelioma: A Comparative Study of Epithelioid Mesothelioma and Lung Adenocarcinoma
N. Ordóñez (2003)
10.1097/DAD.0b013e318236b17f
Role of CD10, Wide-Spectrum Keratin, p63, and Podoplanin in the Distinction of Epithelioid and Spindle Cell Tumors of the Skin: An Immunohistochemical Study of 81 Cases
J. N. Buonaccorsi (2012)
10.1038/modpathol.3880543
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas
H. Kahn (2002)
10.1038/modpathol.3880033
Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3): A Marker of Vascular Tumors with Presumed Lymphatic Differentiation, Including Kaposi's Sarcoma, Kaposiform and Dabska-Type Hemangioendotheliomas, and a Subset of Angiosarcomas
A. Folpe (2000)
Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma.
O. Straume (2003)
Podoplanin (d2-40): a new immunohistochemical marker for reactive follicular dendritic cells and follicular dendritic cell sarcomas.
Q. Xie (2008)
10.1097/PAS.0b013e318033e7a8
h-Caldesmon, Calretinin, Estrogen Receptor, and Ber-EP4: A Useful Combination of Immunohistochemical Markers for Differentiating Epithelioid Peritoneal Mesothelioma From Serous Papillary Carcinoma of the Ovary
C. Comin (2007)
10.1097/DAD.0b013e318233f60a
Tricholemmoma and Clear Cell Squamous Cell Carcinoma (Associated With Bowen's Disease): Immunohistochemical Profile in Comparison to Normal Hair Follicles
N. Misago (2012)
10.1043/1543-2165-133.4.643
Primary pulmonary follicular dendritic cell neoplasm: a case report and review of the literature.
Krista L. Denning (2009)
10.1007/s00428-011-1054-5
Adenomatoid tumors of the female and male genital tract. A comparative clinicopathologic and immunohistochemical analysis of 47 cases emphasizing their site-specific morphologic diversity
D. Wachter (2011)
10.1093/AJCP/86.4.423
Capillary hemangioblastoma. An immunohistochemical study.
S. Holt (1986)
10.1097/PAI.0b013e318229ea89
An Immunohistochemical Study of Adenomatoid Tumors of the Uterus and Fallopian Tube
T. Terada (2012)
10.1097/DAD.0b013e31815ea7c5
Retiform Hemangioendotheliomas Usually do not Express D2-40 and VEGFR-3
Amy L. Parsons (2008)
10.1136/jcp.55.9.662
Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies
A. S. Abutaily (2002)
10.1038/modpathol.3800616
D2-40 antibody immunoreactivity in developing human brain, brain tumors and cultured neural cells
Y. Nakamura (2006)
10.1016/S0002-9440(10)65392-8
VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.
R. Valtola (1999)
10.1093/emboj/cdg342
T1α/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema
V. Schacht (2003)
10.1038/modpathol.3800985
Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma
S. Aishima (2008)
10.1111/j.1600-0560.2006.00461.x
Usefulness of D2‐40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma
E. Arai (2006)
10.1097/PAI.0b013e3181e9fe74
Podoplanin immunostaining in cutaneous apocrine carcinoma and in cutaneous metastasis from the breast.
A. Fernandez-Flores (2010)
10.1097/PAI.0b013e31819d2281
Attenuated Podoplanin Staining in Breast Myoepithelial Cells: A Potential Caveat in the Diagnosis of Lymphatic Invasion
Zhaohai Yang (2009)
10.1159/000086952
Enhanced Expression of Aggrus (T1alpha/Podoplanin), a Platelet-Aggregation-Inducing Factor in Lung Squamous Cell Carcinoma
Y. Kato (2005)
Identification of PA2.26 antigen as a novel cell-surface mucin-type glycoprotein that induces plasma membrane extensions and increased motility in keratinocytes.
F. Scholl (1999)
10.1038/modpathol.3800537
Infantile hemangioma is a proliferation of LYVE-1-negative blood endothelial cells without lymphatic competence
Van An Nguyen (2006)
10.1007/s12105-007-0035-0
Epithelioid Hemangioendothelioma of the Head and Neck: Role of Podoplanin in the Differential Diagnosis
Jabeen Naqvi (2008)
Expression of podoplanin in human bone and bone tumors : a new marker of osteogenic and chondrogenic bone tumors
有泉 高志 (2010)
10.1097/00000478-200302000-00002
Expression of Calretinin, Thrombomodulin, Keratin 5, and Mesothelin in Lung Carcinomas of Different Types: An Immunohistochemical Analysis of 596 Tumors in Comparison With Epithelioid Mesotheliomas of the Pleura
M. Miettinen (2003)
Comparison of Ulex europaeus I lectin and factor VIII-related antigen in vascular lesions.
Ordóñez Ng (1984)
10.1007/s00401-006-0140-2
D2-40 functions as an effective chondroid marker distinguishing true chondroid tumors from chordoma
J. Huse (2006)
10.1038/modpathol.2012.172
Mesothelioma with signet-ring cell features: report of 23 cases
N. Ordóñez (2013)
D2-40 is a novel new marker of malignant mesothelioma (MM): tissue microarray study of 45 MM versus 409 lung carcinomas and primary non-mesothelial neoplasms of the pleura and chest wall [abstract
A Sienko (2005)
10.1038/modpathol.2012.39
Pleomorphic mesothelioma: report of 10 cases
N. Ordóñez (2012)
10.1093/AJCP/76.2.197
Factor VIII in Kaposi's sarcoma.
L. Guarda (1981)
10.1038/modpathol.3800736
D2-40 and calretinin—a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation
Marc Hinterberger (2007)
10.1016/S0046-8177(82)80121-4
Interobserver variation in the identification of breast carcinoma in intramammary lymphatics.
K. Gilchrist (1982)
10.1097/PAS.0b013e31814faacf
Podoplanin is a Better Immunohistochemical Marker for Sarcomatoid Mesothelioma Than Calretinin
Diana M Padgett (2008)
10.1097/PAP.0b013e318271a382
Value of PAX2 Immunostaining in Tumor Diagnosis: A Review and Update
N. Ordóñez (2012)
10.1309/AJCPHSUJ15NEYMIP
A useful antibody panel for differential diagnosis between peritoneal mesothelioma and ovarian serous carcinoma in Japanese cases.
Y. Takeshima (2008)
10.1097/01.LAB.0000028824.03032.AB
A New Monoclonal Antibody, D2-40, for Detection of Lymphatic Invasion in Primary Tumors
H. Kahn (2002)
Podoplanin is a potential marker for the diagnosis of ependymoma: a comparative study with epithelial membrane antigen (EMA).
K. Ishizawa (2009)
10.1038/modpathol.2012.200
Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas
N. Ordóñez (2013)
10.1038/modpathol.2008.108
Immunophenotyping of serous carcinoma of the female genital tract
S. Nofech-Mozes (2008)
Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells.
W. Weninger (1999)
10.1007/s00401-006-0033-4
Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma
K. Mishima (2006)
10.1097/PAI.0b013e3181c65141
Podoplanin Expression in Basal and Myoepithelial Cells: Utility and Potential Pitfalls
W. Kanner (2010)
10.1097/MPH.0b013e3181979c83
Refractory kaposiform hemangioendothelioma that expressed vascular endothelial growth factor receptor (VEGFR)-2 and VEGFR-3: a case report.
M. Saito (2009)
10.1097/00000478-199909000-00002
Papillary intralymphatic angioendothelioma (PILA): a report of twelve cases of a distinctive vascular tumor with phenotypic features of lymphatic vessels.
J. Fanburg-Smith (1999)
10.1097/00000372-199704000-00008
CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma.
J. Goldblum (1997)
10.1016/J.GENE.2006.04.023
Conservation of a platelet activating domain of Aggrus/podoplanin as a platelet aggregation-inducing factor.
M. Kaneko (2006)
Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma.
N. Ordóñez (1998)
10.1038/sj.bjc.6603518
The potential role of podoplanin in tumour invasion
A. Wicki (2007)
10.1111/j.1365-2559.2005.02098.x
Expression of D2‐40 in lymphatic endothelium of normal tissues and in vascular tumours
M. Fukunaga (2005)
10.1002/ijc.21969
Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development
P. Pyakurel (2006)
10.1053/HUPA.2001.24329
Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
C. Comin (2001)
10.1111/j.1600-0463.2007.apm_653.x
Expression of D2‐40 in adjunct diagnosis of papillary thyroid carcinoma
Sheng-Lan Wang (2007)
10.1016/S0012-1606(02)00098-2
T1alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth.
M. I. Ramirez (2003)
10.1097/PAS.0b013e318236c312
Prox1 Transcription Factor as a Marker for Vascular Tumors—Evaluation of 314 Vascular Endothelial and 1086 Nonvascular Tumors
M. Miettinen (2012)
10.1309/7P8U659JBJCV6EEU
Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors.
H. Yu (2007)
10.1016/S0002-9440(10)65583-6
Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors.
A. Lymboussaki (1998)
10.1097/PAI.0b013e318183a8e2
Podoplanin (D2-40) is a Highly Effective Marker of Follicular Dendritic Cells
Derek K Marsee (2009)
10.3892/or.2011.1141
High-level expression of podoplanin in benign and malignant soft tissue tumors: immunohistochemical and quantitative real-time RT-PCR analysis.
Yongjun Xu (2011)
10.1002/(SICI)1098-2744(199709)20:1<10::AID-MC3>3.0.CO;2-M
Induction of PA2.26, a cell‐surface antigen expressed by active fibroblasts, in mouse epidermal keratinocytes during carcinogenesis
A. Gandarillas (1997)
10.1097/PGP.0b013e3181d3261e
Expression of Podoplanin in Epithelial Ovarian Carcinomas and its Potential as a Marker for Clear Cell Adenocarcinoma
S. Oe (2010)
10.5858/arpa.2011-0213-OA
Utility of immunohistochemical staining with FLI1, D2-40, CD31, and CD34 in the diagnosis of acquired immunodeficiency syndrome-related and non-acquired immunodeficiency syndrome-related Kaposi sarcoma.
F. Rosado (2012)
10.1016/S0002-9440(10)65285-6
Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.
S. Breiteneder-Geleff (1999)
10.1111/J.1365-2605.1989.TB01324.X
A novel maturation marker for human Sertoli cells.
R. Baumal (1989)
10.1016/8756-3282(95)00457-2
Characterization and cloning of the E11 antigen, a marker expressed by rat osteoblasts and osteocytes.
A. Wetterwald (1996)
10.1042/0264-6021:3410277
Cloning and characterization of gp36, a human mucin-type glycoprotein preferentially expressed in vascular endothelium.
G. Zimmer (1999)
10.1097/PGP.0b013e3181bbbcc1
Primary Ovarian Mucinous Carcinoma of Intestinal Type: Significance of Pattern of Invasion and Immunohistochemical Expression Profile in a Series of 31 Cases
A. Tabrizi (2010)
10.1038/modpathol.3880489
Extranodal Follicular Dendritic Cell Sarcoma of the Head and Neck Region: Three New Cases, with a Review of the Literature
Dl Biddle (2002)
10.1097/DAD.0b013e31816d6513
Immunohistochemical Expression of D2-40 in Benign and Malignant Sebaceous Tumors and Comparison to Basal and Squamous Cell Carcinomas
Hui-Min Yang (2008)
10.1097/01.pas.0000208280.29291.34
D2-40 is Not a Specific Marker for Cells of Mesothelial Origin in Serous Effusions
A. Bassarova (2006)
10.1097/DAD.0b013e31821b0a9f
Retiform hemangioendothelioma developed on the site of an earlier cystic lymphangioma in a six-year-old girl.
Anne-Fore Albertini (2011)
10.1097/PAS.0b013e3181609d7d
Immunohistochemical Markers to Distinguish Between Hemangioblastoma and Metastatic Clear-cell Renal Cell Carcinoma in the Brain: Utility of Aquaporin1 Combined With Cytokeratin AE1/AE3 Immunostaining
N. Weinbreck (2008)
10.2353/AJPATH.2007.060790
The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis.
A. Kunita (2007)
10.1016/J.HUMPATH.2005.02.007
Intraabdominal cystic lymphangiomas obscured by marked superimposed reactive changes: clinicopathological analysis of a series.
J. Hornick (2005)
10.1111/j.1600-0560.2009.01161.x
Retiform hemangioendothelioma: presentation of a case expressing D2‐40
M. Emberger (2009)
10.1016/j.anndiagpath.2011.02.007
Clinicopathologic and immunohistochemical characteristics of adult primary cardiac angiosarcomas: analysis of 10 cases.
Y. Ge (2011)
10.1186/1471-2199-8-20
Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells
B. Hantusch (2006)
10.1097/PAP.0b013e3182691c2a
Immunohistochemical Endothelial Markers: A Review
N. Ordóñez (2012)
10.1097/PAI.0b013e3181866a13
Immunohistochemical Comparison of Chordoma With Chondrosarcoma, Myxopapillary Ependymoma, and Chordoid Meningioma
H. Cho (2009)
10.1038/modpathol.2008.144
Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis
G. Oakley (2008)
Diagnostic and clinical significance of D2-40 expression in the normal human thymus and thymoma.
M. Raica (2010)
10.1016/J.IMMUNI.2007.07.009
Germinal-center organization and cellular dynamics.
Christopher D. C. Allen (2007)
Comparison of the reactivities of monoclonal antibodies QBEND10 (CD34) and BNH9 in vascular tumors
J Aziza (1993)
Selective immunohistochemical staining of blood and lymphatic vessels reveals independent prognostic influence of blood and lymphatic vessel invasion in early-stage cervical cancer.
P. Birner (2001)
10.1038/modpathol.3800986
Podoplanin is a useful diagnostic marker for epithelioid hemangioendothelioma of the liver
T. Fujii (2008)
10.1038/modpathol.2009.90
Adenomatoid tumors of the female and male genital tracts: a clinicopathological and immunohistochemical study of 44 cases
A. Sangoi (2009)
10.1111/j.1365-2559.1993.tb00138.x
Immunohistochemical markers of carcinoma in situ of the testis also expressed in normal infantile germ cells
N. JφRGENSEN (1993)
10.1097/01.pas.0000149706.74216.b6
Prognostic Value of Lymphatic and Blood Vessel Invasion in Neuroendocrine Tumors of the Lung
K. Schmid (2005)
10.1016/S0002-9440(10)62311-5
Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors.
V. Schacht (2005)
10.1038/modpathol.3800444
D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma
L. Debelenko (2005)
10.1097/DAD.0b013e3181cf8fb4
Immunolabeling Pattern of Podoplanin (D2-40) May Distinguish Basal Cell Carcinomas From Trichoepitheliomas: A Clinicopathologic and Immunohistochemical Study of 49 Cases
J. Plaza (2010)
10.1097/PGP.0b013e318195da86
Embryonic Stem Cell Transcription Factors and D2-40 (Podoplanin) as Diagnostic Immunohistochemical Markers in Ovarian Germ Cell Tumors
M. Chang (2009)
10.1038/modpathol.2012.105
Deciduoid mesothelioma: report of 21 cases with review of the literature
N. Ordóñez (2012)
10.1016/j.humpath.2011.02.029
Folliculocentric B-cell-rich follicular dendritic cells sarcoma: a hitherto unreported morphological variant mimicking lymphoproliferative disorders.
L. Lorenzi (2012)
10.1097/00000478-199609000-00001
Calretinin: a novel immunocytochemical marker for mesothelioma.
C. Doglioni (1996)
10.1002/dc.21599
Malignant effusion of chromophobe renal‐cell carcinoma: Cytological and immunohistochemical findings
P. Teresa (2012)
10.1111/j.1440-1827.2005.01791.x
Podoplanin as a marker for mesothelioma
Noriko Kimura (2005)
10.1128/MCB.02120-05
E11/gp38 Selective Expression in Osteocytes: Regulation by Mechanical Strain and Role in Dendrite Elongation
Keqin Zhang (2006)
[Expression of podoplanin in ovarian clear cell carcinoma].
J. Kotarski (2011)
10.1046/j.1365-2559.2003.01583.x
Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study
D. Lucas (2003)
10.1111/j.1349-7006.2009.01295.x
Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung
Y. Shimada (2009)
10.1038/sj.onc.1207869
Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors
Y. Kato (2004)
10.1038/modpathol.3800749
D2-40 immunohistochemistry in the differential diagnosis of seminoma and embryonal carcinoma: a comparative immunohistochemical study with KIT (CD117) and CD30
S. Lau (2007)
10.1038/modpathol.3800471
The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study
N. Ordóñez (2006)
10.1097/00129039-200503000-00012
Comparison of Monoclonal Versus Polyclonal Calretinin Antibodies for Immunohistochemical Diagnosis of Malignant Mesothelioma
L. Granville (2005)
10.1111/j.1440-1827.2007.02193.x
Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry
K. Kushitani (2008)
10.1074/jbc.M309935200
Molecular Identification of Aggrus/T1α as a Platelet Aggregation-inducing Factor Expressed in Colorectal Tumors*
Y. Kato (2003)
10.1097/01.pap.0000213007.48479.94
Podoplanin: A Novel Diagnostic Immunohistochemical Marker
N. Ordóñez (2006)
10.1111/j.1365-2559.2009.03298.x
Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma
Y. Takeshima (2009)
10.1007/s00428-005-0133-x
Podoplanin is expressed in subsets of tumors of the central nervous system
J. Shibahara (2005)
10.1097/PAS.0b013e3181f6076f
Expression of Prox1, Lymphatic Endothelial Nuclear Transcription Factor, in Kaposiform Hemangioendothelioma and Tufted Angioma
Aude Rimella Le Huu (2010)
10.1007/s00428-006-0223-4
Identity of M2A (D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours
S. B. Sonne (2006)
10.1097/01.pas.0000213388.47913.f1
Podoplanin is a Highly Sensitive and Specific Marker to Distinguish Primary Skin Adnexal Carcinomas From Adenocarcinomas Metastatic to Skin
Haohai Liang (2007)
10.1007/s10014-009-0262-z
Expression of podoplanin and calretinin in meningioma: an immunohistochemical study
M. Shintaku (2009)
10.1097/MPA.0b013e3181975b8c
D2-40 Immunocytochemical Staining for Pancreatic Islets and Pancreatic Endocrine Tumors
T. Tomita (2009)
10.1309/M7D5KTVYYE51XYQA
Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms.
Chris H. Jokinen (2008)
10.1007/s00428-011-1081-2
Podoplanin expression in adamantinoma of long bones and osteofibrous dysplasia
T. Kashima (2011)
10.1084/JEM.194.6.797
Isolation and Characterization of Dermal Lymphatic and Blood Endothelial Cells Reveal Stable and Functionally Specialized Cell Lineages
E. Kriehuber (2001)
10.1007/s00428-005-0130-0
D2-40 staining in sinonasal-type hemangiopericytoma—further evidence of distinction from conventional hemangiopericytoma and solitary fibrous tumor
T. Hansen (2005)
Immunohistochemical staining of germ cell tumors and intratubular malignant germ cells of the testis using antibody to placental alkaline phosphatase and a monoclonal anti-seminoma antibody.
D. Bailey (1991)
10.1165/AJRCMB.14.6.8652186
T1 alpha protein is developmentally regulated and expressed by alveolar type I cells, choroid plexus, and ciliary epithelia of adult rats.
M. C. Williams (1996)
Diagnostic value of markers M2A, OCT3/4, AP-2gamma, PLAP and c-KIT in the detection of extragonadal seminomas. Histopathology
K Biermann (2006)
10.1007/s13277-011-0261-7
Podoplanin expression during dysplasia–carcinoma sequence in the oral cavity
H. Inoue (2011)
10.1097/00000478-200308000-00014
Inhibin Alpha Distinguishes Hemangioblastoma From Clear Cell Renal Cell Carcinoma
M. Hoang (2003)
D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tumor lymphovascular invasion.
Shuyue Ren (2011)
10.1016/j.prp.2011.11.007
Sclerosing Sertoli cell tumor without expression of typical sex cord stromal tumor markers: case report and literature review.
Christopher M. Esber (2012)
10.1111/j.1365-2559.2007.02847.x
Papillary haemangioma. A distinctive cutaneous haemangioma of the head and neck area containing eosinophilic hyaline globules
A. Suurmeijer (2007)
10.1097/DAD.0b013e318234e720
Dilated Lymphatic Vessels in Tufted Angioma: A Potential Source of Diagnostic Confusion
M. Sadeghpour (2012)
10.1016/j.prp.2009.06.001
Is D2-40 a useful marker for distinguishing malignant mesothelioma from pulmonary adenocarcinoma and benign mesothelial proliferations?
H. Deniz (2009)
10.1097/DAD.0b013e31819821c7
Podoplanin Expression in Fibrous Histiocytomas and Cellular Neurothekeomas
S. Kaddu (2009)
10.1002/dvdy.10163
Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate
Young-Kwon Hong (2002)
D2-40 is a novel new marker of malignant mesothelioma (MM): tissue microarray study of 45 MM versus 409 lung carcinomas and primary non-mesothelial neoplasms of the pleura and chest wall
A Sienko (2005)
10.1097/PAS.0b013e318194c566
Distinguishing Chordoid Meningiomas From Their Histologic Mimics: An Immunohistochemical Evaluation
A. Sangoi (2009)
10.1046/j.1365-2559.2000.00981.x
Anti‐mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms
R. Attanoos (2000)
10.1016/j.urology.2006.08.506
MP-11.15: M2A antigen (podoplanin) distribution in prepubertal and adult testes and testicular tumors
I. Sesterhenn (2006)
10.1097/00000478-200101000-00004
Immunohistochemical Panels For Differentiating Epithelial Malignant Mesothelioma From Lung Adenocarcinoma: A Study With Logistic Regression Analysis
R. Carella (2001)
10.1007/s00408-010-9268-x
Clinical Usefulness of D2-40 in Non-Small Cell Lung Cancer
K. Min (2010)
10.1111/j.1440-1827.2007.02148.x
D2‐40‐positive solitary fibrous tumors of the pleura: Diagnostic pitfall of biopsy specimen
Y. Naito (2007)
10.1111/j.1365-2559.2006.02496.x
Diagnostic value of markers M2A, OCT3/4, AP‐2γ, PLAP and c‐KIT in the detection of extragonadal seminomas
K. Biermann (2006)
10.1097/DAD.0b013e31806f1856
Pseudolymphomatous Cutaneous Angiosarcoma: A Rare Variant of Cutaneous Angiosarcoma Readily Mistaken for Cutaneous Lymphoma
L. Requena (2007)
10.1097/PAI.0b013e3181da8387
Value of D2-40 in the Differential Diagnosis of Pleural Neoplasms With Emphasis on Its Positivity in Solitary Fibrous Tumor
Y. Hu (2010)
10.1038/modpathol.3800544
The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study
N. Ordóñez (2006)
10.1111/j.1600-0560.2007.00936.x
Immunohistochemical demonstration of D2‐40 in basal cell carcinomas of the skin
M. Ishida (2008)
10.1034/J.1600-0714.2003.00168.X
Expression of vascular endothelial growth factor-C correlates with the lymphatic microvessel density and the nodal status in oral squamous cell cancer.
R. Sedivy (2003)
10.1038/sj.bjc.6690393
Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours
A. Marks (1999)



This paper is referenced by
10.1002/hed.23761
Prognostic value of S100/CD31 and S100/podoplanin double immunostaining in mucosal malignant melanoma of the head and neck
K. Wermker (2015)
10.1111/cup.12322
Podoplanin expression in cancer‐associated fibroblasts predicts aggressive behavior in melanoma
S. Kan (2014)
10.1007/978-3-662-45133-5_36
Gefäßtumoren der Haut
H. Kutzner (2016)
SQUAMOUS CELL CARCINOMA OF THE ORAL TONGUE: STUDIES OF BIOMARKERS CONNECTED TO HUMAN PAPILLOMAVIRUS INFECTION, EPITHELIAL TO MESENCHYMAL TRANSITION AND LOCOREGIONAL METASTASIS
N. Sgaramella (2017)
10.1007/978-3-319-53577-7_24
Markers and Immunoprofile of Vascular and Perivascular Tumors
Muin S. A. Tuffaha (2018)
10.9734/jpri/2020/v32i1230570
Association of Lympho-vascular Invasion with Various Known Prognostic Markers in Breast Carcinomna
Moumita Dam (2020)
10.1016/j.drudis.2018.07.009
Src and podoplanin forge a path to destruction.
H. Krishnan (2019)
10.1097/PAI.0000000000000142
Podoplanin is Positive Not Only on Follicular Dendritic Cells and Their Tumoral Counterparts, But Also on Reticular Fibroblasts and in Some Tumors of Reticular Fibroblasts
D. Suárez-Vilela (2016)
10.1016/j.humpath.2014.03.006
Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study.
N. Ordóñez (2014)
10.1097/PGP.0000000000000383
Podoplanin and SOX2 Expression in CIN 3–like Squamous Cell Carcinoma of the Cervix
C. Stewart (2018)
10.1055/s-0038-1676120
Malignant Vascular Tumors of the Liver in Adults.
V. Alves (2019)
10.3390/ijms20030707
Podoplanin in Inflammation and Cancer
M. Quintanilla (2019)
10.1016/j.atherosclerosis.2016.02.007
Topologic distributions of vasa vasorum and lymphatic vasa vasorum in the aortic adventitia--Implications for the prevalence of aortic diseases.
M. Sano (2016)
PROGNOSTIC BIOMARKERS AND ROLE OF AGRIN IN PROGRESSION OF ORAL CANCER
BIOMARCADORES PROGNÓSTICOS (2017)
10.1309/AJCPSULJ6DW5REHR
Dual use of E-cadherin and D2-40 immunostaining in unusual meningioma subtypes.
E. K. Mrachek (2015)
10.1186/s12935-020-01328-2
Podoplanin is indispensable for cell motility and platelet-induced epithelial-to-mesenchymal transition-related gene expression in esophagus squamous carcinoma TE11A cells
N. Watanabe (2020)
10.17116/patol20208201168
[Cancer-associated fibroblasts and their significance in tumor progression].
N. A. Oleynikova (2020)
10.1101/164111
Prognostic biomarkers in oral squamous cell carcinoma: a systematic review
C. Rivera (2017)
10.1016/j.oraloncology.2017.07.003
Prognostic biomarkers in oral squamous cell carcinoma: A systematic review.
C. Rivera (2017)
10.1007/s10555-014-9498-0
Platelets and cancer: a casual or causal relationship: revisited
D. Menter (2014)
Head and neck vascular anomalies. A multidisciplinary approach and diagnostic criteria.
L. Moneghini (2017)
10.1016/j.ajpath.2016.06.020
Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90.
B. Nazari (2016)
10.1155/2014/968794
Expression of Mesothelioma-Related Markers in Meningiomas: An Immunohistochemical Study
E. Abdelzaher (2014)
10.1186/s13065-019-0611-x
Graphene-based biosensors for the detection of prostate cancer protein biomarkers: a review
L. Xu (2019)
10.1155/2015/878192
Multiple Congenital Granular Cell Epulis: Case Report and Immunohistochemical Profile with Emphasis on Vascularization
Patrícia Roccon Bianchi (2015)
10.1111/apm.13002
Mediastinal and pleuropulmonary myeloid sarcoma with HBME1 and podoplanin expression. A diagnostic pitfall
D. Suárez-Vilela (2019)
10.1111/cas.13580
Podoplanin: An emerging cancer biomarker and therapeutic target
H. Krishnan (2018)
10.1016/j.jdermsci.2017.03.012
Podoplanin expression in peritumoral keratinocytes predicts aggressive behavior in extramammary Paget's disease.
Z. Cho (2017)
Semantic Scholar Logo Some data provided by SemanticScholar